You are about to leave the Clinical Value website now.

Cancel

Global Talks Lung Cancer Forum

Globa Talks Lung Cancer featured image

Watch this webinar to get updates on advancements in lung cancer treatment, including resectable NSCLC, thoracic surgery, neoadjuvant immunotherapy….

Debate: All resectable stage II to III NSCLC patients should be treated with neoadjuvant immunotherapies

Debate All resectable stage II to III NSCLC patients should be treated with neoadjuvant immunotherapies featured image

Management of early-stage NSCLC with driver mutations

Management of early stage NSCLC with driver mutations featured image

ESMO 2023 Symposium – Redefining Lung Cancer Together: A New Era For Patients

ESMO 2023 1

Missed the satellite symposium session from ESMO 2023? Access the webcast recording here….

Value and Challenges for Precision Oncology Realisation in Real World Practice

Screenshot 2023 11 07 112351

In this interview, Prof Chiu discusses the value of NGS testing to identify lung cancer driver mutations to detect and treat lung cancer early. He also highlights the challenges in its real world implementation. …

APAC Oncology Summit 2023 Webinar

New Project 4